
zzso defined as having low levels of zzso zzso is caused by zzso zzso bone zzso suppression, nutritional zzso or zzso zzso chemotherapy, zzso zzso zzso Although zzso zzso has been shown to improve zzso outcomes in cancer, zzso and chronic kidney disease zzso these results have been viewed in isolation, rather than across zzso The purpose of this article is to review findings from trials that evaluated the impact of zzso zzso on zzso and zzso quality of life zzso across various populations with different underlying causes of zzso 

A review of clinical trials published in English between January 1993 and September zzso zzso were conducted using zzso and zzso zzso and zzso changes in zzso and zzso were zzso 

One hundred ten articles were retrieved and 18 were zzso zzso significant improvements in zzso were generally seen zzso between groups for cancer patients receiving zzso zzso compared with those receiving zzso or standard of care zzso zzso differences in changes from baseline to end point ranging from zzso to zzso zzso and zzso within groups for zzso and zzso patients receiving zzso zzso zzso from baseline to end point of zzso and zzso zzso and zzso zzso zzso zzso and clinically significant improvements in zzso particularly with regard to fatigue, were seen across chronic conditions based on the Linear zzso zzso Assessment energy zzso where improvements of at least 8 zzso clinically zzso generally seen zzso between groups for cancer patients receiving zzso zzso compared with those receiving zzso or zzso zzso in changes from baseline to end point from zzso to zzso zzso and zzso within groups for zzso and zzso patients receiving zzso zzso zzso from baseline to end point of 23 and 25 zzso and 28 zzso zzso 

zzso of published clinical trials suggest that treatment of anemia associated with cancer, zzso and zzso can have a significant impact on zzso particularly fatigue, and that this impact is both statistically and clinically zzso 

